Hideki Tsushima

Nagasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine Monotherapy.

Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine Monotherapy.

Journal: Internal medicine (Tokyo, Japan)

Published: July 09, 2025

A Case of Eltrombopag-Induced Thrombotic Microangiopathy Initiating Hemodialysis.

A Case of Eltrombopag-Induced Thrombotic Microangiopathy Initiating Hemodialysis.

Journal: Cureus

Published: December 18, 2024

Tubulointerstitial nephritis with storiform fibrosis in a patient with angioimmunoblastic T-cell lymphoma.

Tubulointerstitial nephritis with storiform fibrosis in a patient with angioimmunoblastic T-cell lymphoma.

Journal: CEN case reports

Published: February 01, 2024

Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group.

Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group.

Journal: Internal medicine (Tokyo, Japan)

Published: February 22, 2021

No clear survival benefit of azacitidine for lower-risk myelodysplastic syndromes: A retrospective study of Nagasaki.

No clear survival benefit of azacitidine for lower-risk myelodysplastic syndromes: A retrospective study of Nagasaki.

Journal: Cancer science

Published: May 19, 2020

Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm.

Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm.

Journal: International journal of hematology

Published: November 13, 2017

Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Journal: British journal of haematology

Published: August 03, 2017

Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Journal: Cancer science

Published: March 29, 2016

The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.

The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.

Journal: Internal medicine (Tokyo, Japan)

Published: March 12, 2015

Successful treatment with a combination of lenalidomide and dexamethasone for cryoglobulinemia associated with multiple myeloma

Successful treatment with a combination of lenalidomide and dexamethasone for cryoglobulinemia associated with multiple myeloma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 05, 2014

Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience.

Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience.

Journal: International journal of hematology

Published: July 08, 2014

Outcome of patients with relapsed/refractory adult T-cell leukemia-lymphoma after salvage therapy

Outcome of patients with relapsed/refractory adult T-cell leukemia-lymphoma after salvage therapy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 24, 2014

Showing 1-12 of 22

Last Updated: 09/26/2026